Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

RORA boosts autophagy in hair follicle stem cells, potentially aiding hair growth.

The compounds tested could potentially treat hair loss and alopecia.

Certain genetic changes in the LSS gene cause a rare skin and hair condition.

Baricitinib was effective in treating both early and late onset alopecia areata.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

HSD11b1 affects skin nerves and increases non-histaminergic itch.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

The enzyme Rand protease works well for leather dehairing and its stability is important, with Leu75 playing a key role.

New tests detect finasteride and dutasteride in urine quickly and easily.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

A specific mutation in PA-PLA1α causes abnormal hair growth.

Certain circular RNAs may regulate wool follicle growth in sheep.